Lumeon, the company behind the care pathway management platform has raised funding to expand its commercial operations, with advice from BKL.
The funding from Life Sciences Partners, is one the largest healthcare investment firms in Europe, to grow its US team and customer base.
The company will now use the $28 million investment to expand and grow in the US.
Dominic Anthony, Business Services Partner at BKL, said: “We are delighted to be part of Lumeon’s journey as the company grows, helping it to meet the challenges and opportunities that lie ahead.”
“Lumeon is part of a fascinating, fast-changing world, and we at BKL are very focused on helping technology and digital businesses to achieve their potential, particularly in meeting tax and regulatory challenges.”
John Freeman, Chief Financial Officer at Lumeon, said: “Having worked with BKL for a number of years, we were confident in their ability to guide us through a rigorous due diligence process and assist with our plans for the future. The BKL team worked with us to tight deadlines and were a valuable resource on the financial and regulatory issues of a complex transaction.”
